Extract Improves a High-sucrose Diet-induced Metabolic Disorder in
Overview
Authors
Affiliations
(CI) is a traditional medicinal plant used in the treatment of inflammatory diseases. However, the pharmacological role of CI in metabolic diseases, especially in diseases induced by insulin metabolism disorders, remains poorly understood. In the present study, () were fed with high-sugar diet (HSD) to induce a model similar to Type 2 diabetes (T2D) in order to determine whether CI extracts improve the metabolic disorder. It was demonstrated that the CI extracts could improve growth rate, body size, lifespan, reproductive capacity and fat storage, and CI especially improved the fat metabolism and cell size in and mutant flies. In conclusion, the present study provides novel evidence that CI may be an effective drug for the treatment of T2D.
Bauer I, Rimbach G, Cordeiro S, Bosy-Westphal A, Weghuber J, Ipharraguerre I Front Pharmacol. 2024; 15:1396292.
PMID: 38989154 PMC: 11233739. DOI: 10.3389/fphar.2024.1396292.
Lin J, Wang Q, Zhong D, Zhang J, Yuan T, Wu H Front Pharmacol. 2023; 14:1225529.
PMID: 37492087 PMC: 10363978. DOI: 10.3389/fphar.2023.1225529.
Antidiabetes study of (Linn) stem bark fractions in high-sucrose diet-induced diabetes in .
Omoboyowa D, Agoi M, Shodehinde S, Saibu O, Saliu J J Taibah Univ Med Sci. 2023; 18(4):663-675.
PMID: 36845998 PMC: 9947098. DOI: 10.1016/j.jtumed.2023.01.011.
as an Animal Model for Testing Plant-Based Immunomodulators.
Pratomo A, Salim E, Hori A, Kuraishi T Int J Mol Sci. 2022; 23(23).
PMID: 36499123 PMC: 9735809. DOI: 10.3390/ijms232314801.
Ameliorative effect of bayberry leaves proanthocyanidins on high sugar diet induced .
Wang M, Mao H, Chen J, Qi L, Wang J Front Pharmacol. 2022; 13:1008580.
PMID: 36188544 PMC: 9521571. DOI: 10.3389/fphar.2022.1008580.